Table 1 Cohort summary
From: Substantial overlap between symptomatic and asymptomatic genitourinary microbiota states
Clinical variable | Asymptomatic (n = 10) | Positive (n = 48) | Contaminated (n = 6) | No growth (n = 51) | Insignificant (n = 17) |
|---|---|---|---|---|---|
Age (years), mean (SD) | 31.4 (8.77) | 57.9 (21.4) | 58.7 (20.3) | 49.5 (17.8) | 45.2 (22.4) |
Gender, no. (%) | |||||
 Females | 10 (100) | 37 (77.1) | 5 (83.3) | 21 (41.2) | 13 (76.5) |
 Males | 0 | 11 (22.9) | 1 (16.7) | 30 (58.8) | 4 (23.5) |
Race, no. (%) | |||||
 Caucasian | 9 (90) | 28 (58.3) | 3 (50) | 33 (64.7) | 8 (47.1) |
 Black | 0 | 19 (39.6) | 3 (50) | 16 (31.3) | 9 (52.9) |
 Asian | 1 (10) |  |  | 1 (2) | 0 |
 Not specified | 0 | 1 (2.1) | 0 | 1 (2) | 0 |
Patient type, no. (%) | |||||
 Inpatient | 0 | 16 (33.3) | 3 (50) | 12 (23.5) | 4 (23.5) |
 Outpatient | 10 (100) | 31 (64.6) | 3 (50) | 38 (74.5) | 13 (76.5) |
 Not specified | 0 | 1 (2.1) | 0 (0) | 1 (2) | 0 |
Department, no. (%) | |||||
 General medicine |  | 12 (25) | 3 (50) | 21 (41.2) | 5 (29.4) |
 Emergency medicine |  | 9 (18.8) | 0 (0) | 7 (13.7) | 0 (0) |
 Oncology |  | 5 (11.8) | 1 (16.7) | 6 (11.8) | 1 (5.9) |
 Gynecology |  | 4 (8.3) | 1 (16.7) | 4 (7.8) | 4 (23.5) |
 Urology |  | 3 (6.3) | 0 (0) | 3 (5.9) | 3 (17.6) |
 Other |  | 8 (16.7) | 0 (0) | 8 (15.7)) | 1 (5.9) |
 Not specified |  | 7 (14.6) | 1 (16.7) | 2 (3.9) | 3 (17.6) |
Type of urine specimen, no. (%) | |||||
 Catheter | 0 | 3 (6.3) | 0 (0) | 9 (17.6) | 0 (0) |
 Midstream urine | 10 (100) | 19 (39.6) | 6 (100) | 31 (60.8) | 13 (76.5) |
 Not specified | 0 | 26 (54.2) | 0 (0) | 11 (21.6) | 4 (23.5) |